You are viewing: Europe Dental Bone Graft Substitutes Market analysis

The Europe Dental Bone Graft Substitutes Market was valued at $215.33 Million in 2026 and projected to reach to $298.31 Million by 2031, representing a compound annual growth rate of 6.7%. Europe's dental bone graft substitutes market is poised for sustained growth through 2031, expanding from USD 215.33 million to USD 298.31 million.

Europe Dental Bone Graft Substitutes Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

Europe Dental Bone Graft Substitutes Market Trends and Insights

  • This growth in Europe is driven by increasing demand for advanced dental implant procedures, rising prevalence of periodontal disease, and growing adoption of synthetic and allograft bone substitutes across European dental practices.
  • Europe's mature healthcare infrastructure and strong regulatory frameworks support the expansion of innovative bone graft technologies. The European market benefits from high patient awareness, favorable reimbursement policies in key markets, and significant investment in dental research and development.
  • Europe's aging population and emphasis on cosmetic and restorative dentistry further accelerate demand for bone graft substitutes.
  • By 2031, Europe is expected to maintain its position as a key regional market, with continued innovation in biomaterial science and increasing clinical adoption driving sustained growth throughout the forecast period..

Key Market Statistics

  • CAGR (2026-2031) 6.7% CAGR
  • Market Size, 2026 ~USD 215.33 Million
  • Forecast, 2031 ~USD 298.31 Million
  • Geography Europe

Europe Dental Bone Graft Substitutes Market Overview

Market Valuation :

Europe's dental bone graft substitutes market is valued at USD 215.33 million in 2026, with strong growth trajectory projected through 2031.

Growth Momentum :

The European market is expanding at a CAGR of 6.7%, driven by increasing adoption of advanced dental implant procedures and synthetic bone substitutes.

Key Market Drivers :

Rising prevalence of periodontal disease, aging population demographics, and growing preference for allograft and synthetic alternatives are fueling market expansion across Europe.

Regional Leadership :

Germany leads the European market with USD 26.01 million, followed by Italy (USD 17.7 million) and France (USD 11.73 million), reflecting strong healthcare infrastructure and dental innovation.

Europe Dental Bone Graft Substitutes Market Dynamics

  • This growth is underpinned by increasing patient awareness of advanced dental restoration options, rising healthcare expenditure, and strong regulatory support for innovative dental materials.
  • The region's mature healthcare systems and high adoption rates of cutting-edge dental technologies position Europe as a key market for bone graft substitutes. Key European markets including Germany, Italy, and France are driving innovation in synthetic and allograft bone substitutes.
  • Growing prevalence of periodontal disease, combined with an aging population requiring restorative dental procedures, creates sustained demand.
  • Additionally, increasing dental tourism and cross-border patient mobility within Europe are expanding market opportunities for manufacturers and dental practitioners offering advanced bone graft solutions..

Related Ecosystem

Dental Devices

Top Technologies
  • Dental Implants
  • Dental Bone Grafts
  • Dental Crowns
  • Dental Prosthetics
  • Zirconium Implants
Top Companies
  • DENTSPLY SIRONA Inc.
  • Henry Schein, Inc.
  • KAVO KERR GROUP
  • PLANMECA GROUP
  • Patterson Companies, Inc.

    Medical Devices

    Top Technologies
    • Polymerase Chain Reaction (PCR)
    • Magnetic Resonance Imaging (MRI)
    • Disposable Autoinjectors
    • Pulse Oximeters
    • Blood Pressure Monitors
    Top Companies
    • Medtronic plc
    • Abbott Laboratories
    • Stryker Corporation
    • Becton, Dickinson and Company
    • CONMED Corporation

      Key Takeaways

      • Europe's dental bone graft substitutes market is valued at USD 215.33 million in 2026 and will reach USD 298.31 million by 2031, growing at 6.7% CAGR.
      • Europe's mature healthcare infrastructure and favorable reimbursement policies drive strong adoption of advanced bone graft technologies across dental practices.
      • Rising prevalence of periodontal disease and an aging European population increase demand for restorative dental procedures requiring bone graft substitutes.
      • Continued innovation in biomaterial science and synthetic bone substitutes positions Europe as a leading regional market through 2031.

      Dental Bone Graft Substitutes Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment SINUS LIFT (Application)
      Forecast Period 2026–2031
      Growth Rate CAGR of 7.1% from 2026 to 2031
      Largest Segment DENTAL HOSPITALS (End User)
      Market Size Base Year (Billions) ~USD 0.72 (2026)
      Revenue Forecast (Billions) ~USD 1.01 (2031)
      Segments Covered Type, Application, Mechanism, End User

      Europe Dental Bone Graft Substitutes Market Report Segmentation

      4 segment dimensions are covered across the global market.

      By Type

      • Allografts
      • Dbm
      • Other Allografts
      • Other Dental Bone Graft Substitutes
      • Synthetic Bone Grafts
      • Xenografts

      By Application

      • Implant Bone Regeneration
      • Periodontal Defect Regeneration
      • Ridge Augmentation
      • Sinus Lift
      • Socket Preservation

      By Mechanism

      • Osteoconduction
      • Osteogenesis
      • Osteoinduction
      • Osteopromotion

      By End User

      • Dental Clinics
      • Dental Hospitals
      • Other End Users

      REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2024–2031

      Segment20242025202620272028202920302031CAGR (%)
      DENTAL CLINICS9.6610.5210.8711.2811.7512.2812.9713.694.7
      DENTAL HOSPITALS13.2114.4915.0915.7816.5617.4518.5719.755.5
      OTHER END USERS1.51.591.611.631.661.71.751.812.3
      TOTAL24.426.627.628.73031.433.335.35

      EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2024–2031

      Segment20242025202620272028202920302031CAGR (%)
      DENTAL CLINICS76.4581.9786.0590.6795.93101.94109.37117.346.4
      DENTAL HOSPITALS101.9110.14116.56123.81132.06141.47153.01165.497.3
      OTHER END USERS11.8312.412.7213.113.5514.0714.7515.474
      TOTAL190.2204.5215.3227.6241.5257.5277.1298.36.7

      Target Audience

      • Dental Device Manufacturers : Manufacturers need Europe-specific market data to develop localized product strategies, identify key markets (Germany, Italy, France), and optimize distribution networks across the region.
      • Healthcare Investors & PE Firms : Investors require detailed European market forecasts and country-level valuations to assess investment opportunities in dental bone graft companies and identify acquisition targets.
      • Dental Practitioners & Clinics : Dental professionals need market insights to understand product availability, pricing trends, and adoption patterns of bone graft substitutes across European markets.
      • Distributors & Suppliers : Distribution partners require country-specific market data to identify growth opportunities, negotiate supplier agreements, and expand their European dental product portfolios.
      • Market Research & Consulting Firms : Research organizations need comprehensive European market data to support client advisory services, competitive analysis, and strategic planning in the dental healthcare sector.

      Key Companies in the Europe Dental Bone Graft Substitutes Market

      CompanyHQOwnershipStrongest segments
      HOYA CORPORATIONJapanPublic CompanySynthetic Bone Grafts / Alloplast (ceramic fillers, dental),Metallic Implants with integrated grafting use-cases,Other dental biomaterials and adjuncts,
      NOBEL BIOCARESwitzerlandPrivate CompanyXenograft-based grafts (competing with BioOss),Allograft and demineralized grafts (Grafton-adjacent use cases),Synthetic and alloplast grafts (Osteograf-adjacent use cases),
      OSSTEM IMPLANT CO.,LTDSouth KoreaPrivate CompanyXenograft,Allograft,Synthetic Bone Grafts / Alloplast,
      DENTSPLY SIRONA INC.United StatesPublic CompanyXenograft,Allograft,Synthetic Bone Grafts,
      ENVISTAUnited StatesPublic CompanyXenograft-linked biomaterials (BioOss-adjacent competitive set),Allograft and demineralized grafts (Grafton-adjacent competitive set),Synthetic bone grafts,
      ADVANCED MEDICAL SOLUTIONS GROUP PLCUnited KingdomPublic CompanyBiosurgical haemostats used with grafts,Tissue adhesives and wound closure in dental surgery,Internal fixation and clips for oral/maxillofacial,
      ZIMVIE INC.United StatesPrivate CompanyXenograft,Allograft,Synthetic Bone Grafts / Alloplast,
      HENRY SCHEIN, INC.United StatesPublic CompanyXenograft (incl. BioOss distribution),Allograft (incl. Grafton and equivalents),Synthetic Bone Grafts / Alloplast (incl. Osteograf-type products),

      HOYA CORPORATION

      HOYA Corporation is a Japanese public company founded in 1941 that operates with 37,752 employees. The company is a diversified global manufacturer serving multiple industries.

      NOBEL BIOCARE

      Nobel Biocare is a Swiss private company founded in 1981 with 2,552 employees. The company operates in the medical device and healthcare sectors.

      OSSTEM IMPLANT CO.,LTD

      OSSTEM IMPLANT CO.,LTD is a South Korean private company founded in 1997 with 2,817 employees. The company specializes in implant and dental solutions.

      DENTSPLY SIRONA INC.

      DENTSPLY SIRONA INC. is a United States-based public company founded in 2015. The company operates in the dental and healthcare technology industry.

      ENVISTA

      ENVISTA is a United States-based public company founded in 2018 with 12,000 employees. The company operates in the dental and healthcare solutions sector.

      ADVANCED MEDICAL SOLUTIONS GROUP PLC

      Advanced Medical Solutions Group PLC is a United Kingdom-based public company founded in 1991 with 1,800 employees. The company specializes in advanced medical and surgical solutions.

      ZIMVIE INC.

      ZIMVIE INC. is a United States-based private company founded in 2021 with 1,770 employees. The company operates in the medical device and healthcare sector.

      HENRY SCHEIN, INC.

      Henry Schein, Inc. is a United States-based public company founded in 1932 with 25,000 employees. The company is a global distributor of healthcare products and services.

      Europe vs. other regions

      HowEurope compares to the other 3 regional blocs covered in this market.

      North America
      ~USD 382.39 Million · 7.5% wtd CAGR ·
      Asia Pacific
      ~USD 247.46 Million · 7.3% wtd CAGR ·
      Middle East & Africa
      ~USD 28.69 Million · 6.6% wtd CAGR ·
      Latin America
      ~USD 55.48 Million · 5.7% wtd CAGR ·

      Countries within Europe - compare and drill down

      Country2025 size (native)
      GermanyUSD 26.01 Million
      UKUSD 8.85 Million
      FranceUSD 11.73 Million
      ItalyUSD 17.7 Million
      SpainUSD 8.6 Million
      Rest Of EuropeUSD 10.01 Million

      Country market size visualization

      Germany
      USD 26.01 Million
      UK
      USD 8.85 Million
      France
      USD 11.73 Million
      Italy
      USD 17.7 Million
      Spain
      USD 8.6 Million
      Rest Of Europe
      USD 10.01 Million

      Reasons to Buy this Report

      • Market Size & Forecast Data : Access precise valuation of Europe's dental bone graft substitutes market (USD 215.33M in 2026, USD 298.31M in 2031) with country-level breakdowns for Germany, UK, France, Italy, and Spain.
      • Regional Growth Insights : Understand Europe's 6.7% CAGR trajectory and identify high-growth segments within the region, enabling strategic market entry and expansion planning.
      • Competitive Landscape : Benchmark against leading European markets and identify opportunities in underperforming regions to optimize product positioning and distribution strategies.
      • Regulatory & Market Dynamics : Gain insights into European healthcare regulations, reimbursement policies, and adoption trends driving demand for synthetic and allograft bone substitutes.
      • Investment Decision Support : Make informed investment and partnership decisions with comprehensive data on Europe's dental market potential, country-specific opportunities, and growth drivers.

      Frequently asked questions

      What is the current size of Europe's dental bone graft substitutes market?

      Europe's dental bone graft substitutes market is valued at USD 215.33 million in 2026 and is expected to grow to USD 298.31 million by 2031.

      What is the growth rate of the dental bone graft substitutes market in Europe?

      Europe's dental bone graft substitutes market is growing at a compound annual growth rate (CAGR) of 6.7% from 2026 to 2031.

      What factors are driving growth in Europe's dental bone graft substitutes market?

      Key growth drivers in Europe include increasing demand for dental implants, rising prevalence of periodontal disease, favorable reimbursement policies, and growing adoption of synthetic bone substitutes.

      Which European countries are leading the dental bone graft substitutes market?

      Europe's mature healthcare infrastructure supports strong adoption across major markets including Germany, France, the United Kingdom, and Scandinavia, though specific country-level data is aggregated in the regional market valuation.

      What types of bone graft substitutes are most used in Europe?

      Europe's market includes synthetic bone substitutes, allografts, xenografts, and composite materials, with increasing preference for advanced biomaterial solutions that offer improved biocompatibility and clinical outcomes.

      RESEARCH METHODOLOGY

      This study involved four major activities to estimate the current size of the dental bone graft substitutes market. First, extensive secondary research was conducted to gather information on the market, including related and parent markets. The next step was to validate these findings, assumptions, and sizing estimates with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation were used to estimate the market size of segments and subsegments.

      Secondary Research

      The secondary research process involved the extensive use of secondary sources, directories, databases (such as Bloomberg Businessweek, Factiva, and D&B Hoovers), white papers, annual reports, Companies House documents, investor presentations, and SEC filings. Secondary research was used to identify and collect information useful for the extensive, technical, market-oriented, and commercial study of the dental bone graft substitutes market. It was also used to obtain important information on key players, market classification and segmentation aligned with industry trends down to the bottom level, and key developments from market and technology perspectives. A database of the key industry leaders was also prepared using secondary research.

      Primary Research

      In the primary research process, various sources from both the supply and demand sides were interviewed to obtain qualitative and quantitative information for this report. The primary sources on the supply side include industry experts such as CEOs, vice presidents, marketing & sales directors, technology & innovation directors, and other key executives from various companies and organizations operating in the dental bone graft substitutes market. The primary sources on the demand side included industry experts, purchasing & sales managers, doctors, and personnel from research organizations. Primary research was conducted to validate the market segmentation, identify key players, and gather insights into key industry trends and market dynamics.

      Dental Bone Graft Substitutes Market 
 Size, and Share

      Note 1: C-level executives include CEOs, CFOs, COOs, and VPs.
      Note 2: Others include sales managers, marketing managers, business development managers, product managers, distributors, and suppliers.
      Note 3: Companies are classified into tiers based on their total revenue. As of 2025, Tier 1 = >USD 10.00 billion, Tier 2 = USD 1.00 billion to USD 10.00 billion, and Tier 3 = <USD 1.00 billion.

      Source: MarketsandMarkets Analysis

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      For the global market value, annual revenues were calculated using revenue mappings of major product manufacturers and OEMs active in the global dental bone graft substitutes market. All the major product manufacturers were identified at the global and/or country/regional level. Revenue mapping for the respective business segments/subsegments was done for the major players. Also, the global dental bone graft substitutes market was split into various segments and subsegments based on the:

      • List of major players operating in the products market at the regional and/or country level
      • Product mapping of various dental bone graft substitute manufacturers at the regional and/or country level
      • Mapping of annual revenue generated by listed major players from dental bone graft substitutes (or the nearest reported business unit/product category)
      • Revenue mapping of major players to be covered
      • Extrapolation of the revenue mapping of the listed major players to derive the global market value of the respective segments/subsegments
      • Summation of the market value of all segments/subsegments to arrive at the global dental bone graft substitutes market

      The above-mentioned data was consolidated and added with detailed inputs and analysis from MarketsandMarkets and presented in this report.

      Dental Bone Graft Substitutes Market Top Down and Bottom Up Approach

      Data Triangulation

      After determining the overall size of the global dental bone graft substitutes market using the above-mentioned methodology, the market was split into several segments and subsegments. The data triangulation and market breakdown procedures were employed, where applicable, to complete the overall market engineering process and derive the exact market value data for the key segments and subsegments. The extrapolated market data was triangulated by studying various macroindicators and regional trends from both demand- and supply-side participants.

      Market Definition

      A dental bone graft substitute is a biocompatible material used by dentists to rebuild or augment jawbone tissue lost due to various reasons. These substitutes act as a scaffold or supportive structure to promote the growth of new bone tissue in the jaw. They essentially fill the defect or gap where bone loss has occurred.

      Key Stakeholders

      • Manufacturers and distributors of dental bone graft substitutes
      • Manufacturers and distributors of dental bone graft substitute components
      • Dental bone graft substitute companies
      • Healthcare institutes
      • Diagnostic laboratories
      • Dental hospitals and clinics
      • Academic institutes
      • Research institutes
      • Government associations
      • Market research and consulting firms
      • Venture capitalists and investors

      Report Objectives

      • To define, describe, segment, analyze, and forecast the global dental bone graft substitutes market by type, application, mechanism, product, end user, and region
      • To provide detailed information about the factors influencing the market growth (drivers, restraints, opportunities, and challenges)
      • To analyze micromarkets concerning individual growth trends, prospects, and contributions to the overall market
      • To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players
      • To forecast the size of the dental bone graft substitutes market in North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa
      • To profile the key players in the dental bone graft substitutes market and comprehensively analyze their core competencies
      • To track and analyze competitive developments such as agreements, collaborations, and partnerships; expansions; acquisitions; and product launches & approvals in the dental bone graft substitutes market

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

      GEOGRAPHIC ANALYSIS

      • Further breakdown of the Rest of Europe dental bone graft substitutes market into Russia, Switzerland, Denmark, Austria, and others
      • Further breakdown of the Rest of Asia Pacific dental bone graft substitutes market into South Korea, Taiwan, and others
      • Further breakdown of the Rest of Latin America dental bone graft substitutes market into Argentina, Colombia, Chile, Ecuador, and others
      • Further breakdown of the Southeast Asia dental bone graft substitutes market into Malaysia, Singapore, New Zealand, and others

      COMPETITIVE LANDSCAPE ASSESSMENT

      • Market share analysis, by region (North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa), which provides market shares of the top 3–5 key players in the dental bone graft substitutes market
      • Competitive leadership mapping for established players in the US

       

      Get the Full Dental Bone Graft Substitutes Market Report

      Full forecast, segment splits, and company analysis for all Dental Bone Graft Substitutes Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status